Merck Swipes At Surrozen's IP Over Tissue Regrowth Proteins
Merck Sharp and Dohme has attacked a biotechnology company's patent for engineered proteins that help regenerate tissue, just as the pharmaceutical giant's own treatment for damaged eye tissue undergoes its final...To view the full article, register now.
Already a subscriber? Click here to view full article